Literature DB >> 20061811

DNA damage response: a barrier or a path to tumor progression?

George P Studzinski1, Xuening Wang, Michael Danilenko.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20061811      PMCID： PMC2971525          DOI： 10.4161/cbt.9.3.10959

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  27 in total

1.  Microarray analysis of p53 target gene expression patterns in the spleen and thymus in response to ionizing radiation.

Authors:  Timothy F Burns; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2003 Jul-Aug       Impact factor: 4.742

2.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

3.  Different effects of staurosporine, an inhibitor of protein kinases, on the cell cycle and chromatin structure of normal and leukemic lymphocytes.

Authors:  S Bruno; B Ardelt; J S Skierski; F Traganos; Z Darzynkiewicz
Journal:  Cancer Res       Date:  1992-01-15       Impact factor: 12.701

4.  Absence of aminonucleoside-sensitive steps in the cell cycle of SV40-transformed human fibroblasts.

Authors:  J F Gierthy; G P Studzinski
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

5.  Selective inhibition of the cell cycle of cultured human diploid fibroblasts by aminonucleoside of puromycin.

Authors:  G P Studzinski; J F Gierthy
Journal:  J Cell Physiol       Date:  1973-02       Impact factor: 6.384

6.  ATM phosphorylates histone H2AX in response to DNA double-strand breaks.

Authors:  S Burma; B P Chen; M Murphy; A Kurimasa; D J Chen
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

7.  The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways.

Authors:  Jacob Falck; John H J Petrini; Bret R Williams; Jiri Lukas; Jiri Bartek
Journal:  Nat Genet       Date:  2002-02-19       Impact factor: 38.330

8.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

Review 9.  Chk1 and Chk2 kinases in checkpoint control and cancer.

Authors:  Jiri Bartek; Jiri Lukas
Journal:  Cancer Cell       Date:  2003-05       Impact factor: 31.743

Review 10.  Cyclotherapy: protection of normal cells and unshielding of cancer cells.

Authors:  Mikhail V Blagosklonny; Zbigniew Darzynkiewicz
Journal:  Cell Cycle       Date:  2002 Nov-Dec       Impact factor: 4.534
View more
  1 in total

1.  Attenuation of constitutive DNA damage signaling by 1,25-dihydroxyvitamin D3.

Authors:  H Dorota Halicka; Hong Zhao; Jiangwei Li; Frank Traganos; George P Studzinski; Zbigniew Darzynkiewicz
Journal:  Aging (Albany NY)       Date:  2012-04       Impact factor: 5.682
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.